Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaowen Zhang & Nan Wu. (2018) Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells. Drug Design, Development and Therapy 12, pages 373-381.
Read now
Read now
Robert Naeije & Sandrine Huez. (2007) Expert opinion on available options treating pulmonary arterial hypertension. Expert Opinion on Pharmacotherapy 8:14, pages 2247-2265.
Read now
Read now
Articles from other publishers (32)
Massimiliano Mulè, Giulia Passaniti & Daniela Giannazzo. 2023. Novel Pathogenesis and Treatments for Cardiovascular Disease. Novel Pathogenesis and Treatments for Cardiovascular Disease.
Isehaq Al-Huseini, Srinivasa Rao Sirasanagandla, Kondaveeti Suresh Babu, Ramakrishna Gopala Sumesh Sofin & Srijit Das. (2023) Kinase Inhibitors Involved in the Regulation of Autophagy: Molecular
Concepts and Clinical Implications. Current Medicinal Chemistry 30:13, pages 1502-1528.
Crossref
Crossref
Margaret R. MacLean, Barry Fanburg, Nicolas Hill, Howard M. Lazarus, Thomas F. Pack, Michelle Palacios, Krishna C. Penumatsa & Stephen A. Wring. 2011. Comprehensive Physiology. Comprehensive Physiology
4103
4118
.
Lidan Cui, Tianyi Yuan, Zuomei Zeng, Dianlong Liu, Chenxiao Liu, Jian Guo & Yucai Chen. (2022) Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review. Biomedicine & Pharmacotherapy 151, pages 113191.
Crossref
Crossref
Helen Christou & Raouf A. Khalil. (2022) Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. American Journal of Physiology-Heart and Circulatory Physiology 322:5, pages H702-H724.
Crossref
Crossref
Ravikumar Sitapara, TuKiet T. Lam, Aneta Gandjeva, Rubin M. Tuder & Lawrence S. Zisman. (2021) Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension. Pulmonary Circulation 11:3, pages 1-15.
Crossref
Crossref
Philip Cohen, Darren Cross & Pasi A. Jänne. (2021) Kinase drug discovery 20 years after imatinib: progress and future directions. Nature Reviews Drug Discovery 20:7, pages 551-569.
Crossref
Crossref
Upul K. Bandarage, John Court, Huai Gao, Suganthini Nanthakumar, Jon H. Come, Simon Giroux & Jeremy Green. (2021) ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors. Bioorganic & Medicinal Chemistry Letters 33, pages 127721.
Crossref
Crossref
Yanqiu Zhang, Wei Li, Zuhong He, Yunfeng Wang, Buwei Shao, Cheng Cheng, Shasha Zhang, Mingliang Tang, Xiaoyun Qian, Weijia Kong, Hui Wang, Renjie Chai & Xia Gao. (2019) Pre-treatment With Fasudil Prevents Neomycin-Induced Hair Cell Damage by Reducing the Accumulation of Reactive Oxygen Species. Frontiers in Molecular Neuroscience 12.
Crossref
Crossref
Stefan Steurer, Benjamin Hager, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Sarah Minner, Till S. Clauditz, Claudia Hube-Magg, Andreas M. Luebke, Ronald Simon, Jakob R. Izbicki, Eike Burandt, Guido Sauter, Christoph Fraune, Sören Weidemann, Thorsten Schlomm, Hans Heinzer, Alexander Haese, Markus Graefen, Hartwig Huland & Asmus Heumann. (2019) Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer. Aging 11:18, pages 7859-7879.
Crossref
Crossref
Wei Chen, Song Chen, Wenhao Chen, Xian C. Li, Rafik M. Ghobrial & Malgorzata Kloc. (2018) Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts. Transplant Immunology 50, pages 15-25.
Crossref
Crossref
Peng Wu & Amit Choudhary. 2018. Successful Drug Discovery. Successful Drug Discovery
65
93
.
Pratap Karki & Anna A. Birukova. (2018) Substrate stiffness‐dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series). Pulmonary Circulation 8:2, pages 1-9.
Crossref
Crossref
Yuan Dai, Weijia Luo & Jiang Chang. (2018) Rho kinase signaling and cardiac physiology. Current Opinion in Physiology 1, pages 14-20.
Crossref
Crossref
Yhiya Amen, Qinchang Zhu, Hai-Bang Tran, Mohamed S. Afifi, Ahmed F. Halim, Ahmed Ashour & Kuniyoshi Shimizu. (2017) Partial contribution of Rho-kinase inhibition to the bioactivity of Ganoderma lingzhi and its isolated compounds: insights on discovery of natural Rho-kinase inhibitors. Journal of Natural Medicines 71:2, pages 380-388.
Crossref
Crossref
Michiel Alexander de Raaf, Manon Beekhuijzen, Christophe Guignabert, Anton Vonk Noordegraaf & Harm Jan Bogaard. (2015) Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension. Reproductive Toxicology 56, pages 45-51.
Crossref
Crossref
Constantinos M. Mikelis, May Simaan, Koji Ando, Shigetomo Fukuhara, Atsuko Sakurai, Panomwat Amornphimoltham, Andrius Masedunskas, Roberto Weigert, Triantafyllos Chavakis, Ralf H. Adams, Stefan Offermanns, Naoki Mochizuki, Yi Zheng & J. Silvio Gutkind. (2015) RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. Nature Communications 6:1.
Crossref
Crossref
Roxanne H. Croze, David E. Buchholz, Monte J. Radeke, William J. Thi, Qirui Hu, Peter J. Coffey & Dennis O. Clegg. (2014) ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium. Stem Cells Translational Medicine 3:9, pages 1066-1078.
Crossref
Crossref
Casimiro Gerarduzzi, QingWen He, John Antoniou & John A. Di Battista. (2014)
Prostaglandin E
2
-Dependent Blockade of Actomyosin and Stress Fibre Formation Is Mediated Through S1379 Phosphorylation of ROCK2
. Journal of Cellular Biochemistry 115:9, pages 1516-1527.
Crossref
Crossref
Chen Peng, Peng Gu, Jing Zhou, Jianhua Huang & Wei Wang. (2013) Inhibition of Rho-Kinase by Fasudil Suppresses Formation and Progression of Experimental Abdominal Aortic Aneurysms. PLoS ONE 8:11, pages e80145.
Crossref
Crossref
Saurabh Aggarwal, Christine M. Gross, Shruti Sharma, Jeffrey R. Fineman & Stephen M. Black. 2011. Comprehensive Physiology. Comprehensive Physiology
1011
1034
.
Sarwat Chowdhury, Yen Ting Chen, Xingang Fang, Wayne Grant, Jennifer Pocas, Michael D. Cameron, Claudia Ruiz, Li Lin, HaJeung Park, Thomas Schröter, Thomas D. Bannister, Philip V. LoGrasso & Yangbo Feng. (2013) Amino acid derived quinazolines as Rock/PKA inhibitors. Bioorganic & Medicinal Chemistry Letters 23:6, pages 1592-1599.
Crossref
Crossref
Shouan Zhu, Huanhuan Liu, Yan Wu, Boon Heng, Pengfei Chen, Hua Liu & Hong Ouyang. (2013) Wnt and Rho GTPase signaling in osteoarthritis development and intervention: implications for diagnosis and therapy. Arthritis Research & Therapy 15:4, pages 217.
Crossref
Crossref
Dominico Vigil & Channing J. Der. 2013. Inhibitors of the Ras Superfamily G-proteins, Part A. Inhibitors of the Ras Superfamily G-proteins, Part A
193
212
.
Yvette LangdonPanna TandonErika PadenJennifer DuddyJoan M. TaylorFrank L. Conlon. (2012) SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton. Development 139:5, pages 948-957.
Crossref
Crossref
X Jiang & K Chitaley. (2011) The promise of inhibition of smooth muscle tone as a treatment for erectile dysfunction: where are we now?. International Journal of Impotence Research 24:2, pages 49-60.
Crossref
Crossref
I. R. Siddiqui, Shayna Shamim, Devesh Kumar, Shireen & Malik A. Waseem. (2012) Tandem imino-pinacol coupling-aza-Michael reaction promoted by Zn/InCl3: a novel multicomponent strategy for diastereoselective synthesis of monocyclic 1,4-diazepine in water. New Journal of Chemistry 36:11, pages 2209.
Crossref
Crossref
Audrey Courboulin, Roxane Paulin, Nellie J. Giguère, Nehmé Saksouk, Tanya Perreault, Jolyane Meloche, Eric R. Paquet, Sabrina Biardel, Steeve Provencher, Jacques Côté, Martin J. Simard & Sébastien Bonnet. (2011) Role for miR-204 in human pulmonary arterial hypertension. Journal of Experimental Medicine 208:3, pages 535-548.
Crossref
Crossref
Annegret Ulke-Lemée & Justin A. MacDonald. (2010) Opportunities to Target Specific Contractile Abnormalities with Smooth Muscle Protein Kinase Inhibitors. Pharmaceuticals 3:6, pages 1739-1760.
Crossref
Crossref
Alan J. Henderson, Mark Hadden, Cheng Guo, Neema Douglas, Helene Decornez, Mark R. Hellberg, Andrew Rusinko, Marsha McLaughlin, Naj Sharif, Colene Drace & Raj Patil. (2010) 2,3-Diaminopyrazines as rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 20:3, pages 1137-1140.
Crossref
Crossref
Matthias LöhnOliver PlettenburgYuri IvashchenkoAimo KanntArmin HofmeisterDieter KadereitMatthias SchaeferWolfgang LinzMarkus KohlmannJean-Marc HerbertPhilip JaniakStephen E. O'ConnorHartmut Ruetten. (2009) Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor. Hypertension 54:3, pages 676-683.
Crossref
Crossref
Kiran Bhadriraju, John T Elliott, My Nguyen & Anne L Plant. (2007) Quantifying myosin light chain phosphorylation in single adherent cells with automated fluorescence microscopy. BMC Cell Biology 8:1.
Crossref
Crossref